Ava Calabrese
@id-ac.bsky.social
Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative Disorders
✅ Just Accepted
🔗 https://bit.ly/4pVZkuB
✅ Just Accepted
🔗 https://bit.ly/4pVZkuB
January 24, 2026 at 1:35 AM
Narrow-spectrum C difficile antibiotic shows promise in phase 2 study
A small-molecule protein synthesis inhibitor that targets C diff with minimal gut microbiome disruption was found to be highly effective and well-tolerated in a small randomized trial.
www.cidrap.umn.edu/c...
A small-molecule protein synthesis inhibitor that targets C diff with minimal gut microbiome disruption was found to be highly effective and well-tolerated in a small randomized trial.
www.cidrap.umn.edu/c...
January 23, 2026 at 11:47 PM